Currently out of the existing stock ratings of Tejas Savant, 65 are a HOLD (38.92%), 9 are a SELL (5.39%), 93 are a BUY (55.69%).

Tejas Savant

Work Performance Price Targets & Ratings Chart

Analyst Tejas Savant works at MORGAN STANLEY with a stock forecast success ratio of 35.75% fulfilled within 55.29 days on average.

Tejas Savant’s has documented 373 price targets and ratings displayed on 31 stocks. The coverage is on Healthcare, Basic Materials sectors.

Most recent stock forecast was given on OLK, Olink Holding AB ADR at 26-Mar-2024.

Wall Street Analyst Tejas Savant

Analyst best performing recommendations are on NVTA (INVITAE CORP).
The best stock recommendation documented was for NSTG (NANOSTRING TECHNOLOGIES) at 11/10/2020. The price target of $44 was fulfilled within 1 day with a profit of $4.58 (11.62%) receiving and performance score of 116.18.

Average potential price target upside

of $73.08 (16.04%) on TMO (THERMO FISHER SCIENTIFIC).
of $30.02 (15.07%) on IQV (IQVIA HOLDINGS).
of $28.85 (15.11%) on CRL (CHARLES RIVER LABORATORIES).

ADPT Adaptive Biotechnologies Corp AVTR Avantor BDSX Biodesix BLI Berkeley Lights GH Guardant Health NEO NeoGenomics NSTG NanoString Technologies NVTA Invitae Corp SEER Seer TMO Thermo Fisher Scientific TXG 10X Genomics VCYT Veracyte ILMN Illumina CTLT Catalent HOLX Hologic IQV IQVIA Holdings MRVI Maravai Lifesciences Holdings OCDX Ortho Clinical Diagnostics Holdings plc PSNL Personalis CTKB Cytek Biosciences HLTH Cue Health ISO IsoPlexis Corp NAUT Nautilus Biotechnology OLK Olink Holding AB ADR RPID Rapid Micro Biosystems AKYA Akoya Biosciences NTRA Natera PACB Pacific Biosciences of California SOPH Sophia Genetics SA TX Ternium SA ADR CRL Charles River Laboratories

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Mark Massaro (BTIG)